Regulation of LOX and LOXL1 in vaginal tissues during pregnancy, parturition, and the puerperium. A and D: Real-time PCR was used to determine the relative abundance of LOX (A) and LOXL1 (D) mRNA in vaginal tissues from nonpregnant (np) and pregnant wild-type (C3/BL6) mice at various time points in gestation or postpartum. Data are expressed relative to β2-microglobulin and normalized to a nonpregnant vagina standard. Each data point represents mean ± SEM of 5 to 13 tissues at each time point except 72 hours (n = 3). Labor, in labor after delivery of the first pup; 24h, 24 hours postpartum; 48h, 48 hours postpartum; 72h, 72 hours postpartum; 1 wk, 1 week postpartum; 2 wk, 2 weeks postpartum. *P ≤ 0.05 compared with early pregnancy time points. B and E: Immunoblot analysis of LOX (B) and LOXL1 (E) with antibodies that recognize pro- and mature enzymes in vaginal tissues from nonpregnant, pregnant D18, and postpartum (12 to 24 hours) mice. The blot in E is overexposed to detect mature LOXL1 protein because epitopes for antibody recognition are fewer in the mature form compared with the proenzymes. C and F: Relative intensity of chemiluminescence of mature LOX (C) and LOXL1 (F) isoforms in vaginal tissues from nonpregnant (NP, open bars), pregnant D18 (hatched bars), and postpartum (PP, solid bars). LOX and LOXL1 indicate proforms of the enzyme, whereas mature LOX and LOXL1 indicate the final processed forms. Ten μg of urea-extracted protein was applied in each lane. Data represent mean ± SEM of six to eight tissues in each group. *P ≤ 0.05 compared with nonpregnant.